379 related articles for article (PubMed ID: 28934968)
1. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
[TBL] [Abstract][Full Text] [Related]
2. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
[TBL] [Abstract][Full Text] [Related]
3. Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer.
Stuyck C; Wegge M; Bulens P; Joye I; Haustermans K
Acta Oncol; 2017 Nov; 56(11):1501-1506. PubMed ID: 28826304
[TBL] [Abstract][Full Text] [Related]
4. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer.
Cilla S; Caravatta L; Picardi V; Sabatino D; Macchia G; Digesù C; Deodato F; Massaccesi M; De Spirito M; Piermattei A; Morganti AG
Clin Oncol (R Coll Radiol); 2012 May; 24(4):261-8. PubMed ID: 21820294
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study.
Picardi V; Macchia G; Guido A; Giaccherini L; Deodato F; Farioli A; Cilla S; Compagnone G; Ardizzoni A; Cuicchi D; Gambacorta MA; Cellini F; Frezza G; Poggioli G; Valentini V; Fuccio L; Morganti AG
Clin Colorectal Cancer; 2017 Mar; 16(1):16-22. PubMed ID: 27435759
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison.
Macchia G; Cilla S; Morganti AG; Deodato F; Legge F; Piermattei A; Chiantera V; Scambia G; Valentini V; Ferrandina G
Acta Oncol; 2014 Feb; 53(2):251-8. PubMed ID: 24050516
[TBL] [Abstract][Full Text] [Related]
7. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.
Yang Y; Liu Q; Jia B; Du X; Dai G; Liu H; Chen J; Zeng M; Wen K; Zhu Y; Wang Y; Feng L
Technol Cancer Res Treat; 2019 Jan; 18():1533033818824367. PubMed ID: 30803368
[TBL] [Abstract][Full Text] [Related]
9. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity.
Murakami Y; Murakami Y; Kamima T; Oguchi M; Abo N; Takahashi T; Kaneko M; Nakano M; Matsubayashi F; Harada A; Taguchi S; Hashimoto T; Yoshioka Y
Phys Med; 2022 Mar; 95():126-132. PubMed ID: 35158316
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.
Engels B; Tournel K; Everaert H; Hoorens A; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):142-8. PubMed ID: 22014952
[TBL] [Abstract][Full Text] [Related]
12. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.
Fakhrian K; Oechsner M; Kampfer S; Schuster T; Molls M; Geinitz H
Strahlenther Onkol; 2013 Apr; 189(4):293-300. PubMed ID: 23443611
[TBL] [Abstract][Full Text] [Related]
13. Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.
Dröge LH; Weber HE; Guhlich M; Leu M; Conradi LC; Gaedcke J; Hennies S; Herrmann MK; Rave-Fränk M; Wolff HA
BMC Cancer; 2015 Oct; 15():750. PubMed ID: 26486986
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer.
Foroudi F; Wilson L; Bressel M; Haworth A; Hornby C; Pham D; Cramb J; Gill S; Tai KH; Kron T
Radiat Oncol; 2012 Jul; 7():111. PubMed ID: 22824133
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.
Ye W; Shi L; Qian L; Sun Y; Sun X
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108
[TBL] [Abstract][Full Text] [Related]
16. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
[TBL] [Abstract][Full Text] [Related]
17. A comparison of radiotherapy treatment planning techniques in patients with rectal cancers by analyzing testes doses.
Duman E; Bilek Y; Ceyran G
J Cancer Res Ther; 2021; 17(1):56-61. PubMed ID: 33723133
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis.
Kim SY; Baek JY; Oh JH; Park SC; Sohn DK; Kim MJ; Chang HJ; Kong SY; Kim DY
Radiat Oncol; 2017 Mar; 12(1):62. PubMed ID: 28347333
[TBL] [Abstract][Full Text] [Related]
19. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.
Samuelian JM; Callister MD; Ashman JB; Young-Fadok TM; Borad MJ; Gunderson LL
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1981-7. PubMed ID: 21477938
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
